Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
Blood
|
October 15, 1991
Refractory period phenomenon in the induction of tissue factor expression on endothelial cells
N Busso, S Huet, E Nicodème, et al.
Bulletin Du Cancer
|
January 1, 1989
[Pharmacokinetics of pirarubicin (THP-doxorubicin) in patients with cancer]
J Robert, M David, S Huet, et al.
Journal of Applied Toxicology : JAT
|
November 5, 1999
Mutagenicity of malachite green and leucomalachite green in in vitro tests
V Fessard, T Godard, S Huet, et al.
Leukemia
|
March 1, 1990
Pharmacokinetics of idarubicin after oral administration in elderly leukemic patients
J Robert, F Rigal-Huguet, S Huet, et al.
Contact Dermatitis
|
April 20, 1999
Anaphylactic shock after application of chlorhexidine to unbroken skin
J E Autegarden, C Pecquet, S Huet, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell lines
B Schott, D Londos-Gagliardi, C Ries, et al.
Biochemical Pharmacology
|
August 26, 1998
Doxorubicin-induced alterations of c-myc and c-jun gene expression in rat glioblastoma cells: role of c-jun in drug resistance and cell death
P Pourquier, D Montaudon, S Huet, et al.
Human Immunology
|
November 1, 1988
Comparison of signals delivered through CD3 and CD2 for T-cell activation: the role of calcium influx and interleukin 1
H Wakasugi, Y Mahé, S Huet, et al.
Cellular Immunology
|
October 1, 1987
Regulation of helper T cell clone proliferation via the CD2 molecule
G Sterkers, S Huet, L Moachon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1987
Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules
S Huet, L Boumsell, B Raynal, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
Blood
|
October 15, 1991
Refractory period phenomenon in the induction of tissue factor expression on endothelial cells
N Busso, S Huet, E Nicodème, et al.
Bulletin Du Cancer
|
January 1, 1989
[Pharmacokinetics of pirarubicin (THP-doxorubicin) in patients with cancer]
J Robert, M David, S Huet, et al.
Journal of Applied Toxicology : JAT
|
November 5, 1999
Mutagenicity of malachite green and leucomalachite green in in vitro tests
V Fessard, T Godard, S Huet, et al.
Leukemia
|
March 1, 1990
Pharmacokinetics of idarubicin after oral administration in elderly leukemic patients
J Robert, F Rigal-Huguet, S Huet, et al.
Contact Dermatitis
|
April 20, 1999
Anaphylactic shock after application of chlorhexidine to unbroken skin
J E Autegarden, C Pecquet, S Huet, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell lines
B Schott, D Londos-Gagliardi, C Ries, et al.
Biochemical Pharmacology
|
August 26, 1998
Doxorubicin-induced alterations of c-myc and c-jun gene expression in rat glioblastoma cells: role of c-jun in drug resistance and cell death
P Pourquier, D Montaudon, S Huet, et al.
Human Immunology
|
November 1, 1988
Comparison of signals delivered through CD3 and CD2 for T-cell activation: the role of calcium influx and interleukin 1
H Wakasugi, Y Mahé, S Huet, et al.
Cellular Immunology
|
October 1, 1987
Regulation of helper T cell clone proliferation via the CD2 molecule
G Sterkers, S Huet, L Moachon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1987
Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules
S Huet, L Boumsell, B Raynal, et al.
Page
of 7